Family Medicine & Primary Care Review
eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
4/2025
vol. 27
 
Share:
Send email
Share:
Original paper

Prevalence of patients at risk for future osteoporotic fracture among adults in Saudi Arabia

Mohammed Zaid Aljulifi
1
,
Ahmed M. AlMutairi
2
,
Fahad Alfhaid
1
,
Abdulaziz Saud Alanzan
3
,
Mohammed Abdullah Alqadhibi
3
,
Rakan Bejad Almjlad
3
,
Rakan Nahedh Almutairi
3
,
Abdullah Khalid Alharbi
3
,
Abdullah Mohammad bin Aftan
3

  1. Department of Family and Community Medicine, College of Medicine, Majmaah University, Majmaah, Saudi Arabia
  2. Department of Internal Medicine, College of Medicine, Majmaah University, Majmaah, Saudi Arabia
  3. Medical student, College of Medicine, Majmaah University, Saudi Arabia
Family Medicine & Primary Care Review 2025; 27(4)
DOI: https://doi.org/10.5114/fmpcr.2025.156531
Online publish date: 2025/12/22
Article file
- 03 FM&PCR 4 25 - O - Aljulifi - 1805 - Prevalence.pdf  [0.40 MB]
Get citation
 
PlumX metrics:
 
1. Warriner AH, Patkar NM, Curtis D, et al. Which fractures are most attributable to osteoporosis? J Clin Epidemiol 2011; 64: 46–53.
2. Gregson CL, Armstrong DJ, Bowden J, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 2022; 17(1): 58, doi: 10.1007/s11657-022-01061-5. Erratum in: Arch Osteoporos 2022; 17(1): 80, doi: 10.1007/s11657-022-01115-8.
3. Alwahhabi BK. Osteoporosis in Saudi Arabia: Are we doing enough? Saudi Med J 2015; 36: 1149–1150.
4. Sadat-Ali M, Al-Habdan IM, Al-Turki HA, et al. An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population. Ann Saudi Med 2012; 32: 637–641.
5. Händel MN, Cardoso I, Bülow C, von, et al. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ 2023; 381: e068033, doi: 10.1136/bmj-2021-068033.
6. Shevroja E, Reginster JY, Lamy O, et al. Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging. Osteoporos Int 2023; 34(9): 1501–1529, doi: 10.1007/s00198-023-06817-4.
7. Xiao PL, Cui AY, Hsu CJ, et al. Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis. Osteoporos Int 2022; 33(10): 2137–2153, doi: 10.1007/s00198-022-06454-3.
8. Cosman F, Lewiecki EM, Eastell R, et al. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024. J Bone Miner Res 2024; 39(10): 1393–1405, doi: 10.1093/jbmr/zjae119.
9. Lewiecki EM. Osteoporosis: Clinical Evaluation. 2024 Nov 2. In: Feingold KR, Ahmed SF, Anawalt B, et al. (eds). Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.
10. Oommen A, AlZahrani I. Prevalence of osteoporosis and factors associated with osteoporosis in women above 40 years in the Northern Part of Saudi Arabia. Int J Res Med Sci 2014; 2: 274–278.
11. Kanis JA. FRAX WHO fracture risk assessment tool. Sheffield: Centre for Metabolic Bone Diseases, University of Sheffield; 2008.
12. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19(4): 385–397.
13. Noor Z, Sumitro SB, Hidayat M, et al. Assessment of microarchitecture and crystal structure of hydroxyapatite in osteoporosis. Universa Med 2011; 30: 29–35.
14. Horikawa A, Miyakoshi N, Shimada Y, et al. FRAX and Exercise: Should Exercise Be Categorized as a Risk Factor in Osteoporotic Patients. Open J Orthop 2013; 3: 133–136.
15. Papaioannou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010; 182(17): 1864–1873.
16. Al-Daghri NM, Sabico S, Al-Saleh Y, et al. The application of FRAX in Saudi Arabia. Arch Osteoporos 2021; 16(1): 166.
17. Saleh YAL, Sulimani RA, Alomary S, et al. Incidence of hip fracture in Saudi Arabia and the development of a FRAX model. Arch Osteoporos 2022; 17(1): 56.
18. Al Hamam NM, Al-Moaibed GF, Alfayez EH, et al. Prevalence and risk factors for osteoporotic fracture among adults with comorbidities in Al-Ahsaa, Saudi Arabia. J Family Med Prim Care 2020; 9(2): 877–882, doi: 10.4103/jfmpc.jfmpc_982_19.
19. Hammad LF, Benajiba N. Lifestyle factors influencing bone health in young adult women in Saudi Arabia. Afr Health Sci 2017; 17(2): 524–531, doi: 10.4314/ahs.v17i2.28.
20. Sadat-Ali M, Al-Dakheel DA, Azam MQ, et al. Reassessment of osteoporosis-related femoral fractures and economic burden in Saudi Arabia. Arch Osteoporos 2015; 10: 37.
21. Alkhunizan M, Almasoud N, Abdulmowla MM, et al. The Prevalence of Osteoporosis and Osteopenia Among Older Adults in a Community-Based Setting in Riyadh, Saudi Arabia. Cureus 2022; 14(12): e32765.
22. Hettchen M, Stengel S, von, Kohl M, et al. Changes in menopausal risk factors in early postmenopausal osteopenic women after 13 months of high-intensity exercise: the randomized controlled ACTLIFE-RCT. Clin Interv Aging 2021; 16: 83–96, doi: 10.2147/CIA.S283177.
23. Zou X, Ma Z, Liu X, et al. Risk factors and prognostic value of osteoporosis in hospitalized patients with bronchiectasis. BMC Pulm Med 2023; 23(1): 55, doi: 10.1186/s12890-023-02346-2.
24. Starup-Linde J, Støy J, Grinderslev PB, et al. Prevalence and risk factors for osteoporosis in type 1 diabetes – results from an observational study. Osteoporos Int 2025; 36(5): 823–831, doi: 10.1007/s00198-025-07443-y.
25. Hagino H, Uemura Y, Mori S, et al. Risk factors for incident vertebral fractures in osteoporosis pharmacotherapy: a 2-year, prospective, observational study. J Bone Miner Metab 2021; 39(4): 668–677, doi: 10.1007/s00774-021-01208-3.
26. Okawa T, Okawa M, Koike T. Risk factors for poor response to denosumab treatment in Japanese postmenopausal women with osteoporosis. J Bone Miner Metab 2022; 40(6): 960–967, doi: 10.1007/s00774-022-01357-z.
27. Wang Y, Wang L, Sun Y, et al. Prediction model for the risk of osteoporosis incorporating factors of disease history and living habits in physical examination of population in Chongqing, Southwest China: based on artificial neural network. BMC Public Health 2021; 21(1): 991, doi: 10.1186/s12889-021-11002-5.
28. Schwartz AV, Backlund JC, Boer IH, de, et al. Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study. Lancet Diabetes Endocrinol 2022; 10(7): 509–518, doi: 10.1016/S2213-8587(22)00103-6.
29. Zoulakis M, Johansson L, Litsne H, et al. Type 2 diabetes and fracture risk in older women. JAMA Netw Open 2024; 7(8): e2425106, doi: 10.1001/jamanetworkopen.2024.25106.
30. Cuozzo A, Iorio-Siciliano V, Vaia E, et al. Incidence and risk factors associated to medication-related osteonecrosis of the jaw (MRONJ) in patients with osteoporosis after tooth extractions: a 12-months observational cohort study. J Stomatol Oral Maxillofac Surg 2022; 123(6): 616–621, doi: 10.1016/j.jormas.2022.03.020.
31. Lu H, Lary CW, Hodonsky CJ, et al. Association between BMD and coronary artery calcification: an observational and Mendelian randomization study. J Bone Miner Res 2024; 39(4): 443–452, doi: 10.1093/jbmr/zjae022.
32. Kusukawa T, Maruo K, Toi M, et al. Risk factors of domino osteoporotic vertebral fractures is severe paraspinal muscle fatty degeneration. Spine J 2024; 24(12): 2356–2365, doi: 10.1016/j.spinee.2024.08.009.
33. Adami G, Gatti D, Rossini M, et al. Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset. Arch Osteoporos 2021; 16(1): 56, doi: 10.1007/s11657-021-00915-8.
34. Al Zarooni AAR, Nagelkerke N, Al Marzouqi FI, et al. Risk factors for vitamin D deficiency in Abu Dhabi Emirati population. PLOS ONE 2022; 17(2): e0264064, doi: 10.1371/journal.pone.0264064.
35. Mahitthiharn K, Kovindha A, Kaewchur T, et al. Prevalence and influencing factors of spinal cord injury-related osteoporosis and fragility fractures in Thai people with chronic spinal cord injury: a cross-sectional, observational study. J Spinal Cord Med 2023; 46(3): 458–465, doi: 10.1080/10790268.2022.2054763.
36. Tokumoto H, Tominaga H, Maeda S, et al. Risk factors for vertebral fracture in rheumatoid arthritis patients using biological disease-modifying anti-rheumatic drugs (cases over 5 years): an observational study. Medicine (Baltimore) 2024; 103(27): e38740, doi: 10.1097/MD.0000000000038740.
37. Ye C, Morin SN, Lix LM, et al. Age at first fracture and later fracture risk in older adults undergoing osteoporosis assessment. JAMA Netw Open 2024; 7(12): e2448208, doi: 10.1001/jamanetworkopen.2024.48208.
Copyright: © 2025 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.